SCHEMBL1375862

SCHEMBL1375862

Nc1cccc(CC(NCC(F)(F)F)(c2cccnc2)c2cccnc2)n1

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.34
KCNA5 P22460 2/20 0.34
KIF11 P52732 1/20 0.34
CYP19A1 P11511 2/20 0.33
CTSC P53634 1/20 0.33
TSHR P16473 2/20 0.32
KCNH3 Q9ULD8 1/20 0.31
BACE1 P56817 1/20 0.31
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30
HIF1A Q16665 1/20 0.30
MEN1 O00255 2/20 0.30
KMT2A Q03164 2/20 0.30
PSIP1 O75475 1/20 0.30
AXL P30530 1/20 0.30
MKNK1 Q9BUB5 1/20 0.30
MKNK2 Q9HBH9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1377889 0.73 KCNA5 (0.36) KCNA5CYP19A1TSHRBACE1CYP1A2
SCHEMBL1377502 0.72 KCNH3 (0.39) KCNA5CYP19A1KCNH3CYP1A2CYP3A4
SCHEMBL1380498 0.71 CYP3A4 (0.49) L3MBTL1KCNA5CYP19A1CYP1A2CYP3A4
SCHEMBL31508058 0.70 BACE1 (0.42) KCNH3BACE1
SCHEMBL1380210 0.70 KCNA5 (0.40) KCNA5KCNH3BACE1CYP1A2CYP3A4
SCHEMBL1382631 0.69 CYP1A2 (0.37) L3MBTL1KCNA5CYP19A1BACE1CYP1A2
SCHEMBL4197311 0.68 CYP19A1 (0.44) L3MBTL1KCNA5KIF11CYP19A1CYP1A2
SCHEMBL3819751 0.68 CYP1A2 (0.35) L3MBTL1KCNA5CYP19A1BACE1CYP1A2
SCHEMBL3814663 0.66 BACE1 (0.33) KCNA5CYP19A1BACE1CYP1A2CYP3A4
SCHEMBL1380492 0.65 KIF11 (0.35) KIF11CYP19A1CTSCBACE1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4719745-B2 2011-07-06 JP claimed
EP-1781635-A4 POTASSIUM CHANNEL INHIBITORS MERCK & CO INC (US) 2009-02-25 EP claimed
EP-1781635-A2 POTASSIUM CHANNEL INHIBITORS Merck & Co., Inc. (US) 2007-05-09 EP claimed
WO-2006015159-A2 POTASSIUM CHANNEL INHIBITORS MERCK & CO., INC. (US) 2006-02-09 WO claimed